ALX Oncology (ALXO) Short Interest Ratio & Short Volume $1.33 -0.01 (-0.75%) (As of 11/14/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ALX Oncology Short Interest DataALX Oncology (ALXO) has a short interest of 7.84 million shares, representing 25.91% of the float (the number of shares available for trading by the public). This marks a -18.25% decrease in short interest from the previous month. The short interest ratio (days to cover) is 11.2, indicating that it would take 11.2 days of the average trading volume of 779,856 shares to cover all short positions.Current Short Interest7,840,000 sharesPrevious Short Interest9,590,000 sharesChange Vs. Previous Month-18.25%Dollar Volume Sold Short$11.21 millionShort Interest Ratio11.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares52,740,000 sharesFloat Size30,260,000 sharesShort Percent of Float25.91%Today's Trading Volume861,783 sharesAverage Trading Volume779,856 sharesToday's Volume Vs. Average111% Short Selling ALX Oncology? Sign up to receive the latest short interest report for ALX Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALXO Short Interest Over TimeALXO Days to Cover Over TimeALXO Percentage of Float Shorted Over Time Ad Crypto 101 MediaTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late ALX Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20247,840,000 shares $11.21 million -18.3%25.9%11.2 $1.43 10/15/20249,590,000 shares $14.96 million +2.9%31.7%8.8 $1.56 9/30/20249,320,000 shares $16.96 million -6.7%30.9%8.1 $1.82 9/15/20249,990,000 shares $22.18 million +0.1%33.1%8 $2.22 8/31/20249,980,000 shares $23.15 million +7.5%33.0%7.8 $2.32 8/15/20249,280,000 shares $24.59 million +2.2%31.0%6.7 $2.65 Get the Latest News and Ratings for ALXO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ALX Oncology and its competitors with MarketBeat's FREE daily newsletter. 7/31/20249,080,000 shares $43.58 million +17.2%30.5%7.1 $4.80 7/15/20247,750,000 shares $62 million +40.7%26.0%9.1 $8.00 6/30/20245,510,000 shares $33.23 million +30.0%18.5%6.8 $6.03 6/15/20244,240,000 shares $34.13 million +45.7%14.2%5.8 $8.05 5/31/20242,910,000 shares $30.93 million -13.4%10.0%4.3 $10.63 5/15/20243,360,000 shares $50.47 million +6.3%11.6%6.2 $15.02 4/30/20243,160,000 shares $53.78 million -14.4%11.5%6.1 $17.02 4/15/20243,690,000 shares $47.56 million +18.3%13.5%8 $12.89 3/31/20243,120,000 shares $34.79 million +7.2%11.5%8 $11.15 3/15/20242,910,000 shares $32.88 million -16.4%10.7%7.7 $11.30 2/29/20243,480,000 shares $51.05 million -1.4%12.9%7.5 $14.67 2/15/20243,530,000 shares $59.27 million -2.5%13.1%7.8 $16.79 1/31/20243,620,000 shares $52.16 million -1.9%13.2%8 $14.41 1/15/20243,690,000 shares $52.91 million -2.1%13.5%8.2 $14.34 12/31/20233,770,000 shares $56.14 million -6.7%13.8%6.5 $14.89 12/15/20234,040,000 shares $54.74 million +3.1%14.8%2.9 $13.55 11/30/20233,920,000 shares $30.73 million +0.5%17.6%2.9 $7.84 11/15/20233,900,000 shares $34.20 million +2.1%17.5%3.1 $8.77 10/31/20233,820,000 shares $27.50 million -2.1%20.8%3.2 $7.20 10/15/20233,900,000 shares $35.61 million +46.1%21.2%3.3 $9.13 9/30/20232,670,000 shares $12.82 million -11.9%14.5%2.4 $4.80 9/15/20233,030,000 shares $15.70 million -4.1%16.5%19.1 $5.18 8/31/20233,160,000 shares $13.46 million +5.0%17.2%16.6 $4.26 8/15/20233,010,000 shares $14.63 million +2.0%16.5%14.9 $4.86 7/31/20232,950,000 shares $18.02 million +1.0%16.5%14.1 $6.11 7/15/20232,920,000 shares $19.77 million -0.3%16.2%11.2 $6.77 6/30/20232,930,000 shares $22.00 million No Change16.2%9.9 $7.51 6/15/20232,930,000 shares $28.01 million No Change16.2%9.9 $9.56 5/31/20232,930,000 shares $19.54 million +2.1%16.1%9.3 $6.67 5/15/20232,870,000 shares $18.54 million -4.3%16.3%9.8 $6.46 4/30/20233,000,000 shares $17.82 million -23.9%17.0%10.6 $5.94 4/15/20233,940,000 shares $18.91 million +3.4%22.3%15.4 $4.80 3/31/20233,810,000 shares $17.22 million -4.3%21.7%16.9 $4.52 3/15/20233,980,000 shares $20.66 million +3.7%22.6%17.2 $5.19Election warning coming true… (Ad)If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. 2/28/20233,840,000 shares $25.42 million +5.2%21.9%22.1 $6.62 2/15/20233,650,000 shares $28.32 million -5.7%20.8%22.2 $7.76 1/31/20233,870,000 shares $35.99 million -4.4%22.1%22.1 $9.30 1/15/20234,050,000 shares $40.54 million -2.4%23.1%22.8 $10.01 12/30/20224,150,000 shares $46.77 million +0.2%23.7%24.3 $11.27 12/15/20224,140,000 shares $43.72 million -3.0%23.6%29.1 $10.56 11/30/20224,270,000 shares $47.40 million No Change24.3%29.3 $11.10 11/15/20224,270,000 shares $49.53 million -1.8%24.3%26.3 $11.60 10/31/20224,350,000 shares $52.81 million -1.1%23.9%25.5 $12.14 10/15/20224,400,000 shares $48.36 million -3.5%24.1%23.9 $10.99 9/30/20224,560,000 shares $43.64 million No Change25.0%22.6 $9.57 9/15/20224,560,000 shares $57.64 million +6.5%25.0%18.6 $12.64 8/31/20224,280,000 shares $55.64 million +11.8%23.5%11.8 $13.00 8/15/20223,830,000 shares $57.99 million -5.9%21.0%9.4 $15.14 7/31/20224,070,000 shares $39.40 million +4.1%20.5%8.9 $9.68 7/15/20223,910,000 shares $40.51 million -3.5%19.7%8.3 $10.36 6/30/20224,050,000 shares $32.76 million -12.3%20.4%8.7 $8.09 6/15/20224,620,000 shares $30.82 million +5.0%23.2%9.6 $6.67 5/31/20224,400,000 shares $33.75 million +10.6%22.1%11.5 $7.67 5/15/20223,980,000 shares $38.45 million +8.2%20.0%10.6 $9.66 4/30/20223,680,000 shares $47.03 million -6.4%17.9%9.5 $12.78 4/15/20223,930,000 shares $62.92 million -10.9%19.2%8.7 $16.01 3/31/20224,410,000 shares $74.53 million +7.3%21.6%8.7 $16.90 3/15/20224,110,000 shares $68.23 million +3.8%20.1%8.2 $16.60 2/28/20223,960,000 shares $71.76 million -9.2%19.4%6.9 $18.12 2/15/20224,360,000 shares $68.41 million +10.9%21.4%7.4 $15.69 1/31/20223,930,000 shares $62.88 million -11.7%19.6%6.8 $16.00 1/15/20224,450,000 shares $82.33 million +0.9%22.1%9.1 $18.50 12/31/20214,410,000 shares $94.77 million +16.4%21.9%10.6 $21.49 12/15/20213,790,000 shares $93.84 million +11.8%18.8%9.8 $24.76 11/30/20213,390,000 shares $109.02 million +0.6%17.0%11.7 $32.16 11/15/20213,370,000 shares $156.33 million +59.0%16.9%13.6 $46.39 10/29/20212,120,000 shares $118.80 million -8.6%10.8%8.6 $56.04 10/15/20212,320,000 shares $136.86 million +1.3%11.8%9.1 $58.99 9/30/20212,290,000 shares $169.14 million -6.9%11.6%8.7 $73.86 9/15/20212,460,000 shares $192.35 million +2.5%12.5%8.5 $78.19 8/31/20212,400,000 shares $168 million -2.0%12.2%8.3 $70.00 8/13/20212,450,000 shares $163.32 million -6.1%12.5%8.9 $66.66 7/30/20212,610,000 shares $152.84 million +25.5%14.0%10.6 $58.56 7/15/20212,080,000 shares $109.22 million +1.5%11.0%9.8 $52.51 6/30/20212,050,000 shares $112.09 million +1.5%10.9%9.9 $54.68 6/15/20212,020,000 shares $116.78 million -6.5%10.7%11 $57.81 5/28/20212,160,000 shares $122.17 million -5.3%11.5%9.4 $56.56 5/14/20212,280,000 shares $119.91 million +2.7%12.1%9.3 $52.59 4/30/20212,220,000 shares $159.09 million -4.7%12.0%8.7 $71.66 4/15/20212,330,000 shares $139.33 million +2.2%12.6%9.2 $59.80 3/31/20212,280,000 shares $155.77 million +76.7%12.6%9.2 $68.32 3/15/20211,290,000 shares $99.52 million +30.3%7.1%5.1 $77.15 2/26/2021990,000 shares $81.84 million +27.5%5.5%4.3 $82.67 2/12/2021776,800 shares $62.87 million -19.2%4.3%3.6 $80.93Election warning coming true… (Ad)If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. 1/29/2021961,400 shares $74.64 million -17.1%5.3%4.8 $77.64 1/15/20211,160,000 shares $96.29 million No Change6.4%6.4 $83.01 ALXO Short Interest - Frequently Asked Questions What is ALX Oncology's current short interest? Short interest is the volume of ALX Oncology shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 7,840,000 shares of ALXO short. 25.91% of ALX Oncology's shares are currently sold short. Learn More on ALX Oncology's current short interest. What is a good short interest ratio for ALX Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALXO shares currently have a short interest ratio of 11.0. Learn More on ALX Oncology's short interest ratio. What is a good short interest percentage for ALX Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 25.91% of ALX Oncology's floating shares are currently sold short. Is ALX Oncology's short interest increasing or decreasing? ALX Oncology saw a decrease in short interest in October. As of October 31st, there was short interest totaling 7,840,000 shares, a decrease of 18.2% from the previous total of 9,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ALX Oncology's float size? ALX Oncology currently has issued a total of 52,740,000 shares. Some of ALX Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ALX Oncology currently has a public float of 30,260,000 shares. How does ALX Oncology's short interest compare to its competitors? 25.91% of ALX Oncology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ALX Oncology: Atea Pharmaceuticals, Inc. (3.50%), Pyxis Oncology, Inc. (13.30%), Fate Therapeutics, Inc. (13.96%), Mersana Therapeutics, Inc. (8.05%), Kodiak Sciences Inc. (2.67%), Atyr PHARMA INC (2.03%), Zentalis Pharmaceuticals, Inc. (9.91%), SOPHiA GENETICS SA (0.05%), Genfit S.A. (0.13%), Acrivon Therapeutics, Inc. (4.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short ALX Oncology stock? Short selling ALXO is an investing strategy that aims to generate trading profit from ALX Oncology as its price is falling. ALXO shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ALX Oncology? A short squeeze for ALX Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALXO, which in turn drives the price of the stock up even further. How often is ALX Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALXO, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies AVIR Short Interest PYXS Short Interest FATE Short Interest MRSN Short Interest KOD Short Interest ATYR Short Interest ZNTL Short Interest SOPH Short Interest GNFT Short Interest ACRV Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALXO) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
